Furthermore, one study concluded that a KRAS mutation is associated with suppressed Th1/cytotoxic immunity in colorectal cancer [28], which provided a basis for interpreting the association between KRAS mutations and colorectal adenosquamous carcinoma. Here, KRAS is linked to colorectal adenosquamous carcinoma.